Twist Bioscience Corporation
TWST
$120.08
-$5.21-4.16%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -271.90% | -11.93% | 3.44% | 21.69% | 123.83% |
| Total Depreciation and Amortization | 12.37% | 0.16% | -3.06% | -3.75% | -30.55% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | -19.23% | -- |
| Total Other Non-Cash Items | 157.96% | -12.86% | 8.07% | 17.98% | -154.24% |
| Change in Net Operating Assets | 192.12% | 231.86% | -64.18% | -512.54% | -69.89% |
| Cash from Operations | 179.64% | -35.21% | -15.80% | 22.89% | 78.05% |
| Capital Expenditure | -6.52% | -90.32% | -339.77% | -520.73% | -849.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.08% | -277.30% | -94.40% | -96.65% | -1,175.59% |
| Cash from Investing | -8.52% | -791.02% | -546.68% | -865.21% | -1,221.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 107.38% | 29.52% | -89.83% | 53.40% | -37.26% |
| Repurchase of Common Stock | -100.00% | -60.00% | 66.67% | 75.00% | 57.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 107.39% | 29.47% | -98.34% | 53.68% | -37.21% |
| Foreign Exchange rate Adjustments | 114.08% | -105.77% | 116.98% | 123.29% | -3,650.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.54% | -135.18% | -578.89% | -43.20% | -116.37% |